Insulin glargine should not be used past 28 days after the vial is first used, but 80% of patients do.
Diabetes drug empagliflozin reduces fat levels in type 2 patients, which may reduce risk of severe liver disease.
Missing teeth could be a signal that diabetes may be developing.
The immune system could play a beneficial role in regulating insulin, according to a study from Switzerland.
Patients will soon have one less option when selecting insulin.
Type 1 diabetes can present in adults, which can lead to misdiagnosis and unsuccessful treatment.
Having a clinical pharmacist integrated into a medical home benefits diabetes and hypertension patients.
Why it's a good time to become more involved in diabetes education.
Young people with diabetes may do better with insulin pumps than they do with injections.
Interventions by pharmacists can help improve the results of diabetes clinical trials.